Tags

Type your tag names separated by a space and hit enter

[Current diagnosis and treatment of migraine].
Ophthalmologe. 2008 May; 105(5):501-8; quiz 509-10.O

Abstract

Headaches are one of the most common disorders and symptoms in daily medical practice. The prevalence of migraine is 8% in men and 12-15% in women. Dramatic progress in the areas of epidemiology, pathophysiology, and acute and preventive therapy of migraine has been made over the past 100 years, with triptans being the breakthrough for treating acute migraine attacks. Beta blockers, calcium antagonists, and neuromodulators are available for preventive migraine therapy. Nonpharmacologic treatment also plays an important role in migraine prevention. New medical care structures such as integrated headache care provide better support for patients with migraine, particularly those with chronic migraine.

Authors+Show Affiliations

Universitätsklinik für Neurologie und Westdeutsches Kopfschmerzzentrum, Universitätsklinikum Essen, Hufelandstrasse 55, 45147 Essen. h.diener@uni-essen.deNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

18483757

Citation

Diener, H-C, et al. "[Current Diagnosis and Treatment of Migraine]." Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft, vol. 105, no. 5, 2008, pp. 501-8; quiz 509-10.
Diener HC, Katsarava Z, Limmroth V. [Current diagnosis and treatment of migraine]. Ophthalmologe. 2008;105(5):501-8; quiz 509-10.
Diener, H. C., Katsarava, Z., & Limmroth, V. (2008). [Current diagnosis and treatment of migraine]. Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft, 105(5), 501-8; quiz 509-10. https://doi.org/10.1007/s00347-008-1747-6
Diener HC, Katsarava Z, Limmroth V. [Current Diagnosis and Treatment of Migraine]. Ophthalmologe. 2008;105(5):501-8; quiz 509-10. PubMed PMID: 18483757.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Current diagnosis and treatment of migraine]. AU - Diener,H-C, AU - Katsarava,Z, AU - Limmroth,V, PY - 2008/5/17/pubmed PY - 2008/9/23/medline PY - 2008/5/17/entrez SP - 501-8; quiz 509-10 JF - Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft JO - Ophthalmologe VL - 105 IS - 5 N2 - Headaches are one of the most common disorders and symptoms in daily medical practice. The prevalence of migraine is 8% in men and 12-15% in women. Dramatic progress in the areas of epidemiology, pathophysiology, and acute and preventive therapy of migraine has been made over the past 100 years, with triptans being the breakthrough for treating acute migraine attacks. Beta blockers, calcium antagonists, and neuromodulators are available for preventive migraine therapy. Nonpharmacologic treatment also plays an important role in migraine prevention. New medical care structures such as integrated headache care provide better support for patients with migraine, particularly those with chronic migraine. SN - 0941-293X UR - https://www.unboundmedicine.com/medline/citation/18483757/[Current_diagnosis_and_treatment_of_migraine]_ L2 - https://dx.doi.org/10.1007/s00347-008-1747-6 DB - PRIME DP - Unbound Medicine ER -